Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 11:15:1444522.
doi: 10.3389/fpsyg.2024.1444522. eCollection 2024.

Psychiatric disorders in patients with benign and malignant sinonasal tumors: a prospective cross-sectional study

Affiliations

Psychiatric disorders in patients with benign and malignant sinonasal tumors: a prospective cross-sectional study

Guang-Ye Zhan et al. Front Psychol. .

Abstract

Objective: To assess the prevalence of depression, anxiety, insomnia, and somatic symptom disorder (SSD) in patients with benign and malignant sinonasal tumors.

Materials and methods: Pretreatment patients with sinonasal tumors were prospectively recruited on the rhinology ward of a tertiary hospital from July 2021 to March 2022. The electronic questionnaire which contains the rhinological symptom scale, the 22-item Sinonasal Outcome Test (SNOT-22) Scale, the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7), the Insomnia Severity Index (ISI), and the Patient Health Questionnaire-15 (PHQ-15) was filled out by patients at admission. The associations between the scores of symptom/SNOT-22 and psychometric tests were assessed by the Pearson correlation coefficient (r) and simple linear regression. The receiver operating characteristic (ROC) analysis was used to evaluate the performance of the SNOT-22 score in predicting psychiatric disorders.

Results: Thirteen patients with benign sinonasal tumors and 15 patients with malignant sinonasal tumors were recruited. The benign and malignant groups did not differ significantly regarding symptomatology and mental wellbeing. Of the total patients, 9 were at risk of depression (PHQ-9 > 4), 10 were at risk of anxiety (GAD-7 > 4), 11 were at risk of insomnia (ISI > 7), and 11 were at risk of SSD (PHQ-15 > 4). The overall symptom, facial pain/pressure, postnasal drip, and SNOT-22 scores were positively associated with scores of psychometric tests. Patients with a high SNOT-22 score (>18) are likely to be affected by comorbid psychiatric disorders. When interpreting the results of this study, it should be noted that screening tools, not diagnostic tools, were used to identify psychiatric risk.

Conclusion: Depression, anxiety, insomnia, and SSD are prevalent in patients with sinonasal tumors. Otolaryngologists should have a low threshold to ask the patient about psychiatric symptoms, especially for patients with an SNOT-22 score > 18.

Keywords: anxiety; depression; insomnia; sinonasal tumor; somatic symptom disorder.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Violin plots presenting the comparisons between the benign and malignant groups. (A) The rhinological symptom scores; (B) the SNOT-22 score and scores of psychometric tests. Mann–Whitney U-test was used. ns, not significant; PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; ISI, Insomnia Severity Index; PHQ-15, Patient Health Questionnaire-15; SNOT-22, 22-item Sinonasal Outcome Test.
Figure 2
Figure 2
Hot plots presenting the correlations between symptom/SNOT-22 scores and scores of psychometric tests in the whole cohort. (A) The p-values of Pearson correlation; (B) the Pearson correlation coefficients. PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; ISI, Insomnia Severity Index; PHQ-15, Patient Health Questionnaire-15; SNOT-22, 22-item Sinonasal Outcome Test.
Figure 3
Figure 3
Scatter plots with linear fitting curves presenting the correlations between symptom/SNOT-22 scores and scores of psychometric tests in benign and malignant groups separately. PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; ISI, Insomnia Severity Index; PHQ-15, Patient Health Questionnaire-15; SNOT-22, 22-item Sinonasal Outcome Test.
Figure 4
Figure 4
Receiver operating characteristic curves showing the performance of the SNOT-22 score in predicting psychiatric disorders.

Similar articles

References

    1. Annunziata M. A., Muzzatti B., Bidoli E., Flaiban C., Bomben F., Piccinin M., et al. . (2020). Hospital anxiety and depression scale (HADS) accuracy in cancer patients. Support Care Cancer 28, 3921–3926. doi: 10.1007/s00520-019-05244-8, PMID: - DOI - PubMed
    1. Bastien C. H., Vallières A., Morin C. M. (2001). Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med. 2, 297–307. doi: 10.1016/s1389-9457(00)00065-4, PMID: - DOI - PubMed
    1. Bhenswala P. N., Schlosser R. J., Nguyen S. A., Munawar S., Rowan N. R. (2019). Sinonasal quality-of-life outcomes after endoscopic endonasal skull base surgery. Int. Forum Allergy Rhinol. 9, 1105–1118. doi: 10.1002/alr.22398 - DOI - PubMed
    1. Chow V. J., Tsetsos N., Poutoglidis A., Georgalas C. (2022). Quality of life in sinonasal tumors: an up-to-date review. Curr. Opin. Otolaryngol. Head Neck Surg. 30, 46–57. doi: 10.1097/moo.0000000000000774, PMID: - DOI - PubMed
    1. Deckard N. A., Harrow B. R., Barnett S. L., Batra P. S. (2015). Comparative analysis of quality-of-life metrics after endoscopic surgery for sinonasal neoplasms. Am. J. Rhinol. Allergy 29, 151–155. doi: 10.2500/ajra.2015.29.4137, PMID: - DOI - PubMed

LinkOut - more resources